Shanghai Qiansi Biotechnology focuses on providing comprehensive search and procurement services for scientific research reagents. This service covers many areas worthy of in-depth discussion.

Shanghai Qiansi Biotechnology Co., Ltd. is a high-tech biotechnology enterprise.

It mainly provides various products for life science research and so on.

Its products include monoclonal, polyclonal, purified proteins and biological reagents.

In addition, in order to meet the special experimental needs of R&D personnel, we can also provide peptide customization services.

These products are rich in variety and cover almost all biological products needed in scientific research activities. There are particularly many types of cells, nearly 3,000 types, and each type is strictly selected and managed.

It has more advantages in some high-end second- and third-tier products.

Starting these businesses is no easy task, and companies invest a lot of effort in product offerings.

From the purchase of raw materials to the display of finished products, relevant specifications are strictly followed in every aspect to ensure product quality.

Our country's scientific researchers are able to avoid traveling around for purchases, thanks to the rich product supply system.

Many scientific research projects often require the use of a variety of biological reagents. Qiansi Biotechnology Co., Ltd. can meet your needs and allow you to purchase all the reagents you need at one time.

The company has many purchasing agencies distributed around the world, especially in Europe and the United States. In particular, the US headquarters is located in New Jersey, where a professional procurement team of more than 30 people has gathered.

The procurement team is extremely capable, and they are able to introduce a variety of biological products, such as proteins, cells, and laboratory supplies.

This layout enables the company to obtain high-quality biological product resources around the world.

The procurement team assists the company in Europe and the United States and has established agency and cooperative relationships with more than 600 companies, laying a good foundation for the stable development of the relationship between the two parties.

Through collaboration with different partners, the company has successfully collected many products of various shapes. This not only ensures the integrity of product categories, but also enables the continuous introduction of new products and maintains close attention to the cutting-edge of scientific research.

On many occasions, once there are new biological reagents in the research and development stage internationally, we can use this procurement strategy to pay attention in advance and lay a solid foundation for their promotion in the domestic market.

Strict quality control is a major feature of Shanghai Qiansi Biotechnology Co., Ltd.

Through strict management measures, the high performance of the company's products is guaranteed.

For the scientific research process, product quality is crucial.

If the quality of biological reagents is not up to standard, it will directly affect the accuracy of experimental results.

For example, cell products come from institutions such as the American ATCC and are strictly controlled.

Strict quality control reduces the risk of cell contamination.

In the field of scientific research, cell contamination problems are complex and difficult to solve, often hindering the smooth progress of research projects, and rectification is not only time-consuming but also labor-intensive. However, the company has effectively reduced this risk with its strict quality management.

In terms of after-sales service, the company also provides a variety of guarantees.

If contamination is detected in the cell product when it is unopened, the company promises to provide a new cell strain free of charge.

When replacing cell culture medium, we will give detailed guidance. For example, we recommend using half of the culture medium provided by the company and the other half using the customer's own. This will help reduce problems caused by cells not adapting.

There are also clear rules for situations where cell problems can recur.

If the customer's cell status is not good due to incorrect operation, it will not be reissued.

If you encounter problems related to cell viability, customers must submit reliable experimental data within 7 days after receiving the product. After we verify that it is correct, we will replace the product for the customer free of charge and without any charge.

These after-sales service terms give scientific researchers more protection when using products.

The company has a series of things for customers to pay attention to regarding cells.

Regarding matters related to contamination, we hope that customers must submit detailed experimental results within two days after receiving the product.

If the cells die or are contaminated due to improper handling between 8 and 30 days after the user inoculates the cells, the company will provide new original cells at a preferential price.

There are many categories of cell banks. If you want to know the price and detailed information of a specific cell, you must consult the company.

These measures help companies better manage the supply and use of cell products.

Shanghai Qiansi Biotechnology Co., Ltd. has broad development prospects based on the existing foundation.

Research in the field of life sciences continues to make breakthroughs, followed by continued growth in demand for scientific research reagents and cell products.

The company has a diversified product series, strong purchasing capabilities, strict quality management system and thoughtful after-sales service. These advantages will promote its continued expansion in the future market.

The industry has been troubled by some counterfeit and shoddy products, and the company has always been committed to ensuring cell quality and providing authentic cells. This approach will help strengthen communication with domestic scientific researchers and make this connection closer.

What are your expectations or opinions on the future of Shanghai Qiansi Biotechnology Co., Ltd.?